Ligand validation:5QCZ

E5V: (4S)-4-{(S)-hydroxy[(3R,6R)-6-(methoxymethyl)morpholin-3-yl]methyl}-19-(methoxymethyl)-11-oxa-3,16-diazatricyclo[15.3.1.1~6,10~]docosa-1(21),6(22),7,9,17,19-hexaen-2-one

E5V is a Ligand Of Interest in 5QCZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5QCZ_E5V_C_401	63%	76%	0.15	0.945	0.51	0.44	-	-	1	0	100%	0.973
5QCZ_E5V_A_401	56%	73%	0.151	0.924	0.52	0.51	-	-	1	0	100%	0.973
5QCZ_E5V_B_401	53%	75%	0.176	0.94	0.49	0.47	-	-	0	0	100%	0.973

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.